Oramed Pharmaceuticals Inc. (ORMP) Total Return Calculator with Dividends Reinvested

Oramed Pharmaceuticals Inc.

Popular:

The total return for Oramed Pharmaceuticals Inc. (ORMP) stock is +92.09% over the past 12 months. So far it's up 41.92% this year. The 5-year total return is -70.16%, meaning $10,000 invested in ORMP stock 5 years ago would be worth $2,984 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in ORMP 1 year ago, it would be worth $20,296 today — you'd have gained $10,296 with dividends reinvested.

With Dividends Reinvested$20,296+102.96%

Price Only (No DRIP)$19,005+90.05%

Dividend Boost+$1,2911 payments · +12.91% extra

Period2025-06-23 → 2026-06-22

Price

Total Return (DRIP)

Dividends

S&P 500

If You Invested $10,000 in ORMP

1Y$19,209+$9,209 (+92.1%)92.1% CAGR

3Y$10,351+$351 (+3.5%)1.2% CAGR

5Y$2,984-$7,016 (-70.2%)-21.5% CAGR

10Y$4,976-$5,024 (-50.2%)-6.7% CAGR

15Y$10,755+$755 (+7.6%)0.5% CAGR

20Y$3,442-$6,558 (-65.6%)-5.2% CAGR

30Y$3,442-$6,558 (-65.6%)-3.5% CAGR

Dividend Reinvestment History (1)▲ Hide

Ex-Date	Dividend	Reinvest Price	Shares Added
2026-01-16	$0.25	$3.68	+0.067935

Loading ORMP total return...

As of 2026-06-23

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+41.92%	—	+33.33%	+8.59 pp	$14,192
1Y	+92.09%	92.09%	+80.47%	+11.63 pp	$19,209
3Y	+3.51%	1.16%	-2.76%	+6.27 pp	$10,351
5Y	-70.16%	-21.48%	-71.97%	+1.81 pp	$2,984
10Y	-50.24%	-6.74%	-53.25%	+3.01 pp	$4,976
15Y	+7.55%	0.49%	+1.04%	+6.51 pp	$10,755
20Y	-65.58%	-5.19%	-67.67%	+2.08 pp	$3,442
30Y	-65.58%	-3.49%	-67.67%	+2.08 pp	$3,442

Risk & Highlights

Best Year+278.19%2013

Worst Year-81.37%2023

Max Drawdown-23.89%2026-05-14 → 2026-06-02

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+25.95%	+17.35%	+8.6pp	+0.41%	+25.5pp
2025	+18.26%	+18.26%	—	+16.64%	+1.6pp
2024	-1.22%	-1.22%	—	+24.00%	-25.2pp
2023	-81.37%	-81.37%	—	+24.81%	-106.2pp
2022	-13.39%	-13.39%	—	-19.95%	+6.6pp

ORMP outperformed the S&P 500 by 67.10pp over the past year (+92.09% vs +24.99%).

Loading summary...

ORMP Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
ORMPOramed Pharmaceuticals Inc.	$164M	-9.6%	+41.9%	+92.1%	+11.6pp	+3.5%	-70.2%	-50.2%
MNKDMannKind Corporation	$1.2B	+31.8%	-29.6%	+3.4%	—	-2.0%	-7.5%	-24.2%
NRXPNRx Pharmaceuticals, Inc.	$67M	+27.4%	+51.5%	+22.9%	—	-22.5%	-97.3%	-95.9%
PRAXPraxis Precision Medicines, Inc.	$8.8B	-11.9%	-1.4%	+557.0%	—	+1611.0%	-12.5%	-32.3%
NVONovo Nordisk A/S	$204.0B	-2.5%	-15.2%	-39.2%	+2.4pp	-40.6%	+20.8%	+104.7%
LLYEli Lilly and Company	$1.04T	+11.1%	+2.0%	+40.7%	+0.8pp	+146.7%	+413.8%	+1449.6%
SNYSanofi	$100.9B	-2.7%	-7.1%	-5.9%	+5.1pp	-7.7%	+0.2%	+58.1%
VKTXViking Therapeutics, Inc.	$3.8B	+5.9%	-14.2%	+15.6%	—	+39.3%	+394.8%	+2184.2%
AMGNAmgen Inc.	$186.0B	+4.1%	+4.6%	+19.9%	+3.4pp	+59.9%	+59.6%	+171.2%
BMYBristol-Myers Squibb Company	$111.7B	-5.8%	+3.4%	+20.6%	+5.3pp	-7.2%	-1.4%	+4.1%
PFEPfizer Inc.	$142.7B	-0.4%	+3.6%	+12.8%	+7.2pp	-23.0%	-13.7%	+23.7%

Compare:ORMP vs MNKD ORMP vs NRXP ORMP vs PRAX ORMP vs MNKD vs NRXP

About ORMP Dividend Returns

Oramed Pharmaceuticals Inc. (ORMP) is a dividend-paying stock. When dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of ORMP over the past year?

Oramed Pharmaceuticals Inc. (ORMP) delivered a total return of 92.09% over the past year when dividends are reinvested. The price-only return was 80.47%, meaning dividends contributed an additional 11.63 percentage points to total returns.

Q2How much would $10,000 invested in ORMP be worth today?

A $10,000 investment in Oramed Pharmaceuticals Inc. one year ago would be worth $19,209 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $18,047. Dividend reinvestment added $1,163 to the portfolio value.

Q3Does ORMP pay dividends?

Yes, Oramed Pharmaceuticals Inc. (ORMP) pays dividends. In the last year, ORMP paid approximately $0.00 per share in dividends. Reinvesting these dividends through a DRIP can significantly boost long-term returns — over 20+ years, dividend compounding can account for 30–50% of total returns for dividend-paying stocks.

Q4Did ORMP beat the S&P 500?

Yes, Oramed Pharmaceuticals Inc. (ORMP) outperformed the S&P 500 by 67.10 percentage points over the past year. ORMP delivered a total return of 92.09%, compared to the S&P 500's 24.99%. This 67.10pp alpha means investors in ORMP earned more than a passive S&P 500 index fund.

Q5What is ORMP's worst drawdown?

Oramed Pharmaceuticals Inc. (ORMP) experienced a maximum drawdown of -23.89% over the past year, declining from its peak on 2026-05-14 to its trough on 2026-06-02. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is ORMP's long-term total return over 10, 20, or 30 years?

Here are Oramed Pharmaceuticals Inc. (ORMP)'s long-term returns with dividends reinvested. Over 10 years, the total return is -50.2% (-6.7% CAGR) — $10,000 would have grown to $4,976. Over 20 years: -65.6% total return (-5.2% CAGR) — $10,000 → $3,442. Over 30 years: -65.6% total return (-3.5% CAGR) — $10,000 → $3,442. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was ORMP's best and worst year?

Oramed Pharmaceuticals Inc.'s best calendar year was 2013 with a total return of 278.2%. Its worst year was 2023 with a total return of -81.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 359.6 percentage points.

How much would $100/month in ORMP be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →